Qingshuang Zhu1, Pengzhong Fang2, Yadong Zhao1,3, Dingmei Dai1, Xiaofeng Luo1. 1. School of Public Health. 2. The First Clinical Medical College, Lanzhou University. 3. Sexually Transmitted Disease and Acquired Immune Deficiency Syndrome Prevention Branch, Gansu Provincial Center for Disease Control and Prevention, Lanzhou City, Lanzhou, Gansu Province, China.
Abstract
BACKGROUND: Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) has become a pandemic that has infected millions of people around the world and brings a tremendous economic burden. There are numerous guidelines for prevention, diagnosis, and treatment of HIV/AIDS published in recent years, but the quality of these guidelines is still unknown. Therefore, we conducted this study to evaluate the quality of prevention, diagnosis, and treatment of HIV/AIDS published by World Health Organization (WHO) as well as perform a comparison of recommendations between those guidelines. And we also hope our finding could provide suggestions to enhance the quality of future guidelines in this area. METHODS: We obtained guidelines from WHO Guidelines approved by the Guidelines Review Committee (GRC). Two reviewers will independently select eligible guidelines. The quality of included guidelines will be appraised by at least four reviewers through AGREE II and RIGHT tools. The results will be checked for discrepancies. Differences between them than two reviewers will be considered as discrepant and the final discrepancies will be resolved by consensus. The results will be presented in tables and the descriptive statistics will be calculated for all domains of the AGREE II instrument as standard score and median (range) as the reporting quality result of eligible guidelines will also be evaluated through RIGHT criteria. In this study, we will also compare the differences and similarities of recommendations among different guidelines. RESULTS: The results of this study will increase the knowledge about the development of recommendations guidelines for HIV/AIDS of high methodological rigor and reporting quality. This study may also identify potential limitations for future research in this area. CONCLUSION: This study may guide health professionals, policy makers, and health policy managers in choosing the guidelines for recommendation to better to achieve the 90-90-90 targets. INPLASY REGISTRATION NUMBER: INPLASY2020110010.
BACKGROUND: Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) has become a pandemic that has infected millions of people around the world and brings a tremendous economic burden. There are numerous guidelines for prevention, diagnosis, and treatment of HIV/AIDS published in recent years, but the quality of these guidelines is still unknown. Therefore, we conducted this study to evaluate the quality of prevention, diagnosis, and treatment of HIV/AIDS published by World Health Organization (WHO) as well as perform a comparison of recommendations between those guidelines. And we also hope our finding could provide suggestions to enhance the quality of future guidelines in this area. METHODS: We obtained guidelines from WHO Guidelines approved by the Guidelines Review Committee (GRC). Two reviewers will independently select eligible guidelines. The quality of included guidelines will be appraised by at least four reviewers through AGREE II and RIGHT tools. The results will be checked for discrepancies. Differences between them than two reviewers will be considered as discrepant and the final discrepancies will be resolved by consensus. The results will be presented in tables and the descriptive statistics will be calculated for all domains of the AGREE II instrument as standard score and median (range) as the reporting quality result of eligible guidelines will also be evaluated through RIGHT criteria. In this study, we will also compare the differences and similarities of recommendations among different guidelines. RESULTS: The results of this study will increase the knowledge about the development of recommendations guidelines for HIV/AIDS of high methodological rigor and reporting quality. This study may also identify potential limitations for future research in this area. CONCLUSION: This study may guide health professionals, policy makers, and health policy managers in choosing the guidelines for recommendation to better to achieve the 90-90-90 targets. INPLASY REGISTRATION NUMBER: INPLASY2020110010.
Authors: Melissa C Brouwers; Michelle E Kho; George P Browman; Jako S Burgers; Francoise Cluzeau; Gene Feder; Béatrice Fervers; Ian D Graham; Jeremy Grimshaw; Steven E Hanna; Peter Littlejohns; Julie Makarski; Louise Zitzelsberger Journal: J Clin Epidemiol Date: 2010-07-24 Impact factor: 6.437
Authors: Yaolong Chen; Kehu Yang; Ana Marušic; Amir Qaseem; Joerg J Meerpohl; Signe Flottorp; Elie A Akl; Holger J Schünemann; Edwin S Y Chan; Yngve Falck-Ytter; Faruque Ahmed; Sarah Barber; Chiehfeng Chen; Mingming Zhang; Bin Xu; Jinhui Tian; Fujian Song; Hongcai Shang; Kun Tang; Qi Wang; Susan L Norris Journal: Ann Intern Med Date: 2016-11-22 Impact factor: 25.391
Authors: Annie Haakenstad; Mark W Moses; Tianchan Tao; Golsum Tsakalos; Bianca Zlavog; Jennifer Kates; Adam Wexler; Christopher J L Murray; Joseph L Dieleman Journal: Lancet HIV Date: 2019-04-26 Impact factor: 12.767